| Table 3. Information on national evaluations providing data to the Interbull | ||||||
| routine evaluation for clinical mastitis, as provided by participating countries | ||||||
| proof | ||||||
| Country | Breed(s) | h2 | model | expression* | ||
|
|
||||||
| Denmark | AYS HOL JER | .04 | SM MT | RBV(-) | ||
| Finland | AYS HOL | .05 | SM | RTA(-) | ||
| Norway | AYS | .035 | SM | RTA(-) | ||
| Sweden | AYS HOL | .02 | SM | RBV(-) | ||
|
|
||||||
| *reversed scale, i.e. high values are desirable, indicated with in parenthesis | ||||||